UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer

The New England journal of medicine, 2023-06, Vol.388 (22), p.2058-2070

2023

Volltextzugriff (PDF)

Culinary strategies to manage glycemic response in people with type 2 diabetes: A narrative review

Frontiers in nutrition (Lausanne), 2022-11, Vol.9, p.1025993-1025993

2022

Volltextzugriff (PDF)

Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer

Breast (Edinburgh), 2021-04, Vol.56, p.35-41

2021

Volltextzugriff (PDF)

A time-restricted feeding intervention in children and adolescents with obesity: The TRansForm study protocol

Frontiers in nutrition (Lausanne), 2022-10, Vol.9, p.1026694-1026694

2022

Volltextzugriff (PDF)

Circulating miR-192 and miR-193b Are Markers of Prediabetes and Are Modulated by an Exercise Intervention

The journal of clinical endocrinology and metabolism, 2015-03, Vol.100 (3), p.E407-E415

2015

Volltextzugriff (PDF)

People with type 1 diabetes exhibit lower exercise capacity compared to a control population with similar physical activity levels

Diabetes research and clinical practice, 2024-05, Vol.211, p.111655-111655, Article 111655

2024

Volltextzugriff (PDF)

Muscular carnosine is a marker for cardiorespiratory fitness and cardiometabolic risk factors in men with type 1 diabetes

European journal of applied physiology, 2022-06, Vol.122 (6), p.1429-1440

2022

Volltextzugriff (PDF)

High Intensity Interval Training reduces hypoglycemic events compared with continuous aerobic training in individuals with type 1 diabetes

Diabetes & metabolism, 2022-11, Vol.48 (6), p.101361, Article 101361

2022

Volltextzugriff (PDF)

Management of Hypoglycemia in Adults with Type 1 Diabetes in Real-Life Condition

Annals of nutrition and metabolism, 2020-12, Vol.76 (4), p.277-284

2020

Volltextzugriff (PDF)

Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus

PloS one, 2012-07, Vol.7 (7), p.e40600-e40600

2012

Volltextzugriff (PDF)

De-escalation neoadjuvant chemotherapy in triple negative breast cancer

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e12520-e12520

2024

Volltextzugriff (PDF)

Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer

Future science OA, 2021-03, Vol.7 (3), p.FSO672

2021

Volltextzugriff (PDF)

Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-naïve patients with type 2 diabetes: a pilot randomized trial

Lipids in health and disease, 2016-04, Vol.15 (1), p.78-78, Article 78

2016

Volltextzugriff (PDF)

Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy

PloS one, 2015-08, Vol.10 (8), p.e0136348-e0136348

2015

Volltextzugriff (PDF)

Protocol for regional implementation of collaborative self-management services to promote physical activity

BMC health services research, 2018-07, Vol.18 (1), p.560-560, Article 560

2018

Volltextzugriff (PDF)

Abstract PO4-03-12: De-escalating treatment with neoadjuvant chemotherapy in early triple-negative breast cancer

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO4-03-12-PO4-03-12

2024

Volltextzugriff (PDF)

AIPAC-003: A randomized, double-blind, placebo-controlled phase 3 trial testing eftilagimod alpha (soluble LAG-3) in patients with HER2-neg/low metastatic breast cancer receiving paclitaxel, following an open-label dose optimization

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS1120-TPS1120

2023

Volltextzugriff (PDF)

Methods for selection of neoadjuvant treatment with chemotherapy for patients with hormone receptor-positive and HER2-negative with early breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e12591-e12591

2023

Volltextzugriff (PDF)

Influencing factors of the recurrence after neoadjuvant therapy in HER2-positive breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e12608-e12608

2022

Volltextzugriff (PDF)

Abstract P2-12-10: Improving pathological complete response in luminal breast cancer after neoadjuvant chemotherapy

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-12-10

2022

Volltextzugriff (PDF)

21-gene recurrence score assay as a predictor of pathological response in neoadjuvant chemotherapy administration for ER-positive/HER2-negative early-stage breast cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e12630-e12630

2020

Volltextzugriff (PDF)

High Intensity Interval Training reduces hypoglycemic events compared with continuous aerobic training in individuals with type 1 diabetes: HIIT and hypoglycemia in type 1 diabetes

Diabetes & metabolism, 2022-11, Vol.48 (6), p.101361-101361

2022

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(72)
Buchkapitel
(2)

Sprache

Englisch
(72)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(19)
Humans
(15)
Female
(10)
Oncology
(8)
Adult
(7)
Diabetes
(7)
Exercise
(7)
Middle Aged
(7)
Patients
(7)
Breast Cancer
(6)
Breast Neoplasms - Pathology
(6)
Male
(6)
Breast Neoplasms - Drug Therapy
(5)
Diabetes Mellitus
(5)
Endocrine Therapy
(5)
Physical Activity
(5)
Aged
(4)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer

Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial

Culinary strategies to manage glycemic response in people with type 2 diabetes: A narrative review

Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer

A time-restricted feeding intervention in children and adolescents with obesity: The TRansForm study protocol

Circulating miR-192 and miR-193b Are Markers of Prediabetes and Are Modulated by an Exercise Intervention

People with type 1 diabetes exhibit lower exercise capacity compared to a control population with similar physical activity levels

Muscular carnosine is a marker for cardiorespiratory fitness and cardiometabolic risk factors in men with type 1 diabetes

Low Physical Activity and Its Association with Diabetes and Other Cardiovascular Risk Factors: A Nationwide, Population-Based Study

High Intensity Interval Training reduces hypoglycemic events compared with continuous aerobic training in individuals with type 1 diabetes

Management of Hypoglycemia in Adults with Type 1 Diabetes in Real-Life Condition

Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus

De-escalation neoadjuvant chemotherapy in triple negative breast cancer

Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer

Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-naïve patients with type 2 diabetes: a pilot randomized trial

Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial

Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy

Protocol for regional implementation of collaborative self-management services to promote physical activity

Abstract PO4-03-12: De-escalating treatment with neoadjuvant chemotherapy in early triple-negative breast cancer

AIPAC-003: A randomized, double-blind, placebo-controlled phase 3 trial testing eftilagimod alpha (soluble LAG-3) in patients with HER2-neg/low metastatic breast cancer receiving paclitaxel, following an open-label dose optimization

Methods for selection of neoadjuvant treatment with chemotherapy for patients with hormone receptor-positive and HER2-negative with early breast cancer

Influencing factors of the recurrence after neoadjuvant therapy in HER2-positive breast cancer

Abstract P2-12-10: Improving pathological complete response in luminal breast cancer after neoadjuvant chemotherapy

21-gene recurrence score assay as a predictor of pathological response in neoadjuvant chemotherapy administration for ER-positive/HER2-negative early-stage breast cancer

High Intensity Interval Training reduces hypoglycemic events compared with continuous aerobic training in individuals with type 1 diabetes: HIIT and hypoglycemia in type 1 diabetes

Suchergebnisse filtern